Top Markets
#1 ADO Protocol ADO Protocol +337.07%
#2 GoPlus Security GoPlus Security +52.45%
#3 Starpower Starpower +36.27%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.77%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +20.07%
#7 Nockchain Nockchain +18.00%
#8 Fake World Assets Fake World Assets +17.14%
#9 DMT-NAT DMT-NAT +14.82%
#10 Casper Network Casper Network +11.97%
Coin of the day
ADO Protocol ADO Protocol
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Bharat Immunologicals & Biologicals Corporation Limited Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limited

BIBCL
Hisse Senetlerindeki Sıralama #33468
Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology... Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc tablets, comprehensive diarrhea management kits, and ready-to-consume therapeutic foods. The firm organizes its operations into several key divisions: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. Founded on March 10, 1989, the company's main office is situated in Bulandshahr, India.
Hisse Fiyatı
$0.17580153
Piyasa Değeri
$7.59M
Değişim (1 gün)
-0.13%
Değişim (1 yıl)
-30.21%
Ülke
IN
Ticaret Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)

Kategori

Healthcare
Bharat Immunologicals & Biologicals Corporation Limited (BIBCL) için gelir
Aug 2026 itibarıyla gelir TTM: 0
Bharat Immunologicals & Biologicals Corporation Limited şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Bharat Immunologicals & Biologicals Corporation Limited için 2026 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US